India's demand for weight-loss drugs is surging, with Eli Lilly's Mounjaro and Novo Nordisk's Wegovy competing for dominance. The obesity drug market has grown fivefold since 2021, driven by ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...